We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CFXA market cap is 9.7B. The company's latest EPS is USD -0.6092 and P/E is -73.49.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 417.52M | 455.02M | 516.27M | 525.16M | 505.22M |
| Operating Income | -20.49M | -8.46M | -35.01M | -44.22M | -31.74M |
| Net Income | -2.88M | 2.96M | -72M | -18.64M | -31.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.33B | 3.07B | 3.85B | 1.6B | 1.71B |
| Operating Income | 207.81M | 165.79M | 256.42M | -71.78M | -68.41M |
| Net Income | -527.65M | 42.63M | 72.14M | -13.29M | -33.26M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.4B | 4.51B | 5.48B | 5.44B | 5.55B |
| Total Liabilities | 959.19M | 1.09B | 2.17B | 2.15B | 2.22B |
| Total Equity | 3.44B | 3.42B | 3.31B | 3.29B | 3.33B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.39B | 7.35B | 8.52B | 4.27B | 4.51B |
| Total Liabilities | 3.9B | 3.76B | 3.85B | 823.45M | 1.09B |
| Total Equity | 3.49B | 3.59B | 4.66B | 3.45B | 3.42B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 66.57M | 134.99M | -36.16M | -28.38M | 25.17M |
| Investing | -183.1M | -242.47M | -797.84M | -839.17M | -897.59M |
| Financing | 125.01M | 127.8M | 864.54M | 867.05M | 866.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 130.95M | 301.94M | 356.1M | -55.86M | 134.99M |
| Investing | -1.63B | -175.08M | -320.48M | -176.39M | -242.47M |
| Financing | 1.37B | -131.65M | 584.91M | -465.13M | 127.8M |
| Market Cap | 9.7B |
| Price to Earnings Ratio | -73.49 |
| Price to Sales Ratio | 1.43 |
| Price to Cash Ratio | 67.54 |
| Price to Book Ratio | 0.71 |
| Dividend Yield | - |
| Shares Outstanding | 54.59M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 9.9 (5.24%) |
| Company Name | Colfax Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.enovis.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
